Acorah Software Products - Accounts Production 19.2.450 false true false true No description of principal activity 5 October 2024 31 October 2025 31 October 2025 15999598 Miss Mikisha Makwana iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure 15999598 2024-10-04 15999598 2025-10-31 15999598 2024-10-05 2025-10-31 15999598 frs-core:CurrentFinancialInstruments 2025-10-31 15999598 frs-bus:PrivateLimitedCompanyLtd 2024-10-05 2025-10-31 15999598 frs-bus:FilletedAccounts 2024-10-05 2025-10-31 15999598 frs-bus:Micro-entities 2024-10-05 2025-10-31 15999598 frs-bus:AuditExempt-NoAccountantsReport 2024-10-05 2025-10-31 15999598 frs-bus:Director1 2024-10-05 2025-10-31
Registered number: 15999598
Makwana Pharmaceuticals Ltd
Unaudited Financial Statements
For the Period 5 October 2024 to 31 October 2025
Balance Sheet
Registered number: 15999598
31 October 2025
£
Fixed assets 1,340
Current assets 83,412
Creditors: Amounts Falling Due Within One Year (69,728 )
NET CURRENT ASSETS 13,684
TOTAL ASSETS LESS CURRENT LIABILITIES 15,024
Accruals and deferred income (975 )
NET ASSETS 14,049
CAPITAL AND RESERVES 14,049

Notes

1. General Information
Makwana Pharmaceuticals Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 15999598 . The registered office is 37 Marlands Road, Ilford, IG5 0JL.
2. Average Number of Employees
Average number of employees, including directors, during the period was: 1
1
For the period ending 31 October 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
On behalf of the board
Miss Mikisha Makwana
Director
28/06/2026